Clover May

Clover is an associate in the Emerging Companies and M&A team in London. She specialises in advising companies and investors in the technology and life science sectors on venture capital investments, M&A transactions and general corporate matters.

Actualités et publications récentes

View Clover's insights

Cliquer ici pour en savoir plus

Sciences de la vie et Santé

Advising on Tropic Biosciences' US$105 million Series C financing

25 mars 2026

par plusieurs auteurs

Droit Social, pensions et mobilité

New legislation governing Allocation of Tips to come into force in July 2024

21 mars 2024

Quick read

par Clover May

Cliquer ici pour en savoir plus

Accords d'intéressement

Lexology Executive Compensation & Employee Benefits 2023 - UK chapter

14 novembre 2023

par plusieurs auteurs

Cliquer ici pour en savoir plus

Clover May

Expertise

Services et Groupes

Secteurs

Actualités et publications récentes

Advising on Tropic Biosciences' US$105 million Series C financing

Clover May

Expertise

Services et Groupes

Secteurs

Actualités et publications récentes

Advising on Tropic Biosciences' US$105 million Series C financing

Related news & insights

#7: State of the EU Crypto Industry: MiCA, Tokenisation and What Comes Next

Online coaching and distance learning: Federal Court of Justice clarifies application of the Distance Learning Protection Act

Proposed Amendments to the EU Medical Device Regulation

The 2026 Pharma Package: A New Regulatory Framework for Medicinal Products in the EU

Impact of the new Biotech Act on Clinical Trials in the EU

Advising Eurofins on the sale of its electrical and electronic testing business for EUR575 million

Advising on Sona's US$45 million Series B funding

Life Sciences Legal Lens – Vol. 1

Taylor Wessing strengthens Corporate/M&A practice with Equity Partner Jan Hückel

Hungary opens health data infrastructure for AI development

Autres avocats qui pourraient vous intéresser

Rendez-vous à